Effects of grape seed proanthocyanidin extract on menopausal symptoms, body composition, and cardiovascular parameters in middle-aged women: a randomized, double-blind, placebo-controlled pilot study. 2014

Masakazu Terauchi, and Noe Horiguchi, and Asuka Kajiyama, and Mihoko Akiyoshi, and Yoko Owa, and Kiyoko Kato, and Toshiro Kubota
From the Departments of 1Women's Health and 2Obstetrics and Gynecology, Tokyo Medical and Dental University, Tokyo, Japan.

OBJECTIVE This study aims to assess the effects of proanthocyanidin-a class of polyphenol antioxidants extracted from grape seeds-on menopausal symptoms, body composition, and cardiovascular parameters in middle-aged women. METHODS We conducted a randomized, double-blind, placebo-controlled study in 96 women aged 40 to 60 years who had at least one menopausal symptom. The study participants were randomized to receive grape seed extract tablets containing either low-dose (100 mg/d) or high-dose (200 mg/d) proanthocyanidin, or placebo, for 8 weeks. Their menopausal symptoms were evaluated using the Menopausal Health-Related Quality of Life Questionnaire, Hospital Anxiety and Depression Scale, and Athens Insomnia Scale before and after 4 and 8 weeks of treatment. Body composition and cardiovascular parameters were also measured. RESULTS A total of 91 women (95%) completed the study. Background characteristics, including age, menopause status, subjective symptom scores, body composition, and cardiovascular parameters, were similar among the groups. The following significant changes were observed during the course of the study: (1) physical symptom score, hot flash score, and (2) Athens Insomnia Scale score decreased in the high-dose group after 8 weeks of treatment; (3) Hospital Anxiety and Depression Scale Anxiety score and (4) systolic and diastolic blood pressure decreased in the low-dose and high-dose groups after 4 weeks; and, (5) lastly, muscle mass increased in the low-dose and high-dose groups after 8 weeks of treatment. CONCLUSIONS Grape seed proanthocyanidin extract is effective in improving the physical and psychological symptoms of menopause while increasing muscle mass and reducing blood pressure in middle-aged women.

UI MeSH Term Description Entries
D008593 Menopause The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age. Change of Life, Female
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010865 Pilot Projects Small-scale tests of methods and procedures to be used on a larger scale if the pilot study demonstrates that these methods and procedures can work. Pilot Studies,Pilot Study,Pilot Project,Project, Pilot,Projects, Pilot,Studies, Pilot,Study, Pilot
D010938 Plant Oils Oils derived from plants or plant products. Oils, Plant,Oils, Vegetable,Plant Oil,Vegetable Oil,Vegetable Oils,Oil, Plant,Oil, Vegetable
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D001823 Body Composition The relative amounts of various components in the body, such as percentage of body fat. Body Compositions,Composition, Body,Compositions, Body
D003324 Coronary Artery Disease Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause. Arteriosclerosis, Coronary,Atherosclerosis, Coronary,Coronary Arteriosclerosis,Coronary Atherosclerosis,Left Main Coronary Artery Disease,Left Main Coronary Disease,Left Main Disease,Arterioscleroses, Coronary,Artery Disease, Coronary,Artery Diseases, Coronary,Atheroscleroses, Coronary,Coronary Arterioscleroses,Coronary Artery Diseases,Coronary Atheroscleroses,Left Main Diseases
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females

Related Publications

Masakazu Terauchi, and Noe Horiguchi, and Asuka Kajiyama, and Mihoko Akiyoshi, and Yoko Owa, and Kiyoko Kato, and Toshiro Kubota
November 2019, Nutrients,
Masakazu Terauchi, and Noe Horiguchi, and Asuka Kajiyama, and Mihoko Akiyoshi, and Yoko Owa, and Kiyoko Kato, and Toshiro Kubota
January 2018, Nutrition journal,
Masakazu Terauchi, and Noe Horiguchi, and Asuka Kajiyama, and Mihoko Akiyoshi, and Yoko Owa, and Kiyoko Kato, and Toshiro Kubota
September 2020, Taiwanese journal of obstetrics & gynecology,
Masakazu Terauchi, and Noe Horiguchi, and Asuka Kajiyama, and Mihoko Akiyoshi, and Yoko Owa, and Kiyoko Kato, and Toshiro Kubota
February 2022, Complementary therapies in clinical practice,
Masakazu Terauchi, and Noe Horiguchi, and Asuka Kajiyama, and Mihoko Akiyoshi, and Yoko Owa, and Kiyoko Kato, and Toshiro Kubota
March 2024, Nutrition research (New York, N.Y.),
Masakazu Terauchi, and Noe Horiguchi, and Asuka Kajiyama, and Mihoko Akiyoshi, and Yoko Owa, and Kiyoko Kato, and Toshiro Kubota
August 2021, Journal of menopausal medicine,
Masakazu Terauchi, and Noe Horiguchi, and Asuka Kajiyama, and Mihoko Akiyoshi, and Yoko Owa, and Kiyoko Kato, and Toshiro Kubota
January 2008, Nutrition (Burbank, Los Angeles County, Calif.),
Masakazu Terauchi, and Noe Horiguchi, and Asuka Kajiyama, and Mihoko Akiyoshi, and Yoko Owa, and Kiyoko Kato, and Toshiro Kubota
September 2017, Phytotherapy research : PTR,
Masakazu Terauchi, and Noe Horiguchi, and Asuka Kajiyama, and Mihoko Akiyoshi, and Yoko Owa, and Kiyoko Kato, and Toshiro Kubota
December 2020, Nutrients,
Masakazu Terauchi, and Noe Horiguchi, and Asuka Kajiyama, and Mihoko Akiyoshi, and Yoko Owa, and Kiyoko Kato, and Toshiro Kubota
September 2023, Nutrients,
Copied contents to your clipboard!